InterCure Ltd. (INCR)

InterCure Income Statement

Financials in millions ILS. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	355.55	388.68	219.68	65.04	8.93
Revenue Growth (YoY)	-8.52%	76.93%	237.78%	628.60%	-
Cost of Revenue	250.46	233.6	128.55	33.06	7.45
Gross Profit	105.1	155.08	91.13	31.98	1.48
Selling, General & Admin	95.88	92.62	50.42	17.03	14.77
Research & Development	0.39	0.63	1.24	1.58	1.71
Other Operating Expenses	3.26	9.08	8.32	47.2	47.38
Operating Expenses	99.52	102.33	59.98	65.81	63.86
Operating Income	5.57	52.76	31.16	-33.84	-62.38
Interest Expense / Income	19.72	6.79	9.45	0.53	3.29
Other Expense / Income	45.56	1.06	5.57	5.13	-59.1
Pretax Income	-59.71	44.91	16.13	-39.5	-6.57
Income Tax	2.25	0.09	11.44	-2.27	-0.67
Net Income	-61.96	44.82	4.69	-37.23	-5.89
Net Income Growth	-	855.63%	-	-	-
Shares Outstanding (Basic)	46	45	43	43	-
Shares Change	0.97%	5.64%	-	-	-
EPS (Basic)	-1.36	0.99	0.12	-1.42	-0.25
EPS (Diluted)	-1.36	0.99	0.11	-1.42	-0.25
EPS Growth	-	800.00%	-	-	-
Free Cash Flow	-56.23	31.53	16.11	-12.95	-39.71
Free Cash Flow Per Share	-1.23	0.70	0.38	-0.30	-
Gross Margin	29.56%	39.90%	41.48%	49.17%	16.57%
Operating Margin	1.57%	13.57%	14.18%	-52.03%	-698.82%
Profit Margin	-17.43%	11.53%	2.13%	-57.25%	-66.02%
Free Cash Flow Margin	-15.81%	8.11%	7.33%	-19.90%	-444.91%
Effective Tax Rate	-	0.21%	70.93%	-	-
EBITDA	-39.99	51.7	25.58	-38.97	-3.27
EBITDA Margin	-11.25%	13.30%	11.65%	-59.92%	-36.68%
EBIT	-39.99	51.7	25.58	-38.97	-3.27
EBIT Margin	-11.25%	13.30%	11.65%	-59.92%	-36.68%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).